Shandong Wit Dyne HealthLtd 관리

관리 기준 확인 2/4

We currently do not have sufficient information about the CEO.

주요 정보

Jie Yang

최고 경영자

CN¥4.8m

총 보상

CEO 급여 비율	n/a
CEO 임기	12.5yrs
CEO 소유권	n/a
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	3.3yrs

최근 관리 업데이트

Recent updates

Is There An Opportunity With Shandong Wit Dyne Health Co.,Ltd.'s (SZSE:000915) 38% Undervaluation?

Oct 27

There's No Escaping Shandong Wit Dyne Health Co.,Ltd.'s (SZSE:000915) Muted Earnings

Sep 14

Shandong Wit Dyne HealthLtd (SZSE:000915) Is Increasing Its Dividend To CN¥2.00

May 12

Shandong Wit Dyne HealthLtd's (SZSE:000915) Earnings Offer More Than Meets The Eye

Apr 24

CEO

Jie Yang (62 yo)

12.5yrs

테뉴어

CN¥4,803,800

보상

Ms. Jie Yang served as a Vice Chairman of The Board of Directors at Shandong Shanda WIT Science & Technology Co., Ltd and has been its Director since May 16, 2012. Ms. Yang serves as Managing Director of...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Jie Yang	MD & Director	12.5yrs	CN¥4.80m	데이터 없음
Da Yu Zhang	Deputy GM & Director	3.3yrs	CN¥652.80k	데이터 없음
Xiaoping Zhu	Chairman	16.5yrs	데이터 없음	데이터 없음
Yuqin Lu	Independent Director	4.5yrs	CN¥80.00k	데이터 없음
Du Ning	Independent Director	2.6yrs	CN¥80.00k	데이터 없음
Shangjun Ren	Shareholder Supervisor	6.3yrs	데이터 없음	데이터 없음
Baojie Shen	Director	3.3yrs	데이터 없음	데이터 없음
Shucang Cheng	Director	3.3yrs	데이터 없음	데이터 없음
Zhiyuan Zhang	Independent Director	3.3yrs	CN¥80.00k	데이터 없음
Hongyin Tian	Supervisor	3.3yrs	데이터 없음	데이터 없음
Tingting Zhan	Shareholder Representative Supervisor	less than a year	데이터 없음	데이터 없음
Ling Wang	Chairman of Supervisory Board	less than a year	데이터 없음	데이터 없음

3.3yrs

평균 재임 기간

53.5yo

평균 연령

경험이 풍부한 이사회: 000915's board of directors are considered experienced (3.3 years average tenure).

Shandong Wit Dyne HealthLtd 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Shandong Wit Dyne Health Co.,Ltd., Annual General Meeting, Apr 16, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Is There An Opportunity With Shandong Wit Dyne Health Co.,Ltd.'s (SZSE:000915) 38% Undervaluation?

Third quarter 2024 earnings released: EPS: CN¥0.14 (vs CN¥0.60 in 3Q 2023)

Investor sentiment deteriorates as stock falls 17%

Shandong Wit Dyne Health Co.,Ltd. to Report Q3, 2024 Results on Oct 26, 2024

Investor sentiment improves as stock rises 20%

There's No Escaping Shandong Wit Dyne Health Co.,Ltd.'s (SZSE:000915) Muted Earnings

New minor risk - Dividend sustainability

Second quarter 2024 earnings released: EPS: CN¥0.70 (vs CN¥0.67 in 2Q 2023)

Shandong Wit Dyne Health Co.,Ltd. to Report First Half, 2024 Results on Aug 01, 2024

Shandong Wit Dyne HealthLtd (SZSE:000915) Is Increasing Its Dividend To CN¥2.00

Dividend increased to CN¥2.00

Shandong Wit Dyne Health Co.,Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 16 May 2024

Shandong Wit Dyne HealthLtd's (SZSE:000915) Earnings Offer More Than Meets The Eye

First quarter 2024 earnings released: EPS: CN¥0.72 (vs CN¥0.70 in 1Q 2023)

Shandong Wit Dyne Health Co.,Ltd. to Report Q1, 2024 Results on Apr 18, 2024

Shandong Wit Dyne Health Co.,Ltd., Annual General Meeting, Apr 16, 2024

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Full year 2023 earnings released: EPS: CN¥2.49 (vs CN¥2.25 in FY 2022)

Shandong Wit Dyne Health Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 16, 2024

Third quarter 2023 earnings released: EPS: CN¥0.60 (vs CN¥0.67 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.67 (vs CN¥0.63 in 2Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.67 (vs CN¥0.63 in 2Q 2022)

Shandong Shanda Wit Science and Technology Co., Ltd. to Report First Half, 2023 Results on Aug 19, 2023

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Full year 2022 earnings released: EPS: CN¥2.21 (vs CN¥1.62 in FY 2021)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.67 (vs CN¥0.38 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.63 (vs CN¥0.51 in 2Q 2021)

Less than half of directors are independent

Shandong Shanda Wit Science and Technology Co., Ltd. Approves Cash Dividend for 2021

Full year 2021 earnings: EPS and revenues miss analyst expectations

Full year 2021 earnings: EPS and revenues miss analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.38 (vs CN¥0.39 in 3Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥0.51 (vs CN¥0.37 in 2Q 2020)

Investor sentiment improved over the past week

Shandong Shanda Wit Science and Technology Co., Ltd. Announces 2020 Final Distribution Plan, Payable on 01 June 2021

First quarter 2021 earnings released: EPS CN¥0.47 (vs CN¥0.21 in 1Q 2020)

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥1.25 (vs CN¥0.87 in FY 2019)

Shandong Shanda Wit Science and Technology Co., Ltd. to Report Fiscal Year 2020 Results on Mar 27, 2021

New 90-day low: CN¥22.35

Full year 2020 earnings released: EPS CN¥1.25

New 90-day low: CN¥24.00

New 90-day low: CN¥25.78

Third quarter earnings released

Shandong Shanda Wit Science and Technology Co., Ltd. to Report Q3, 2020 Results on Oct 24, 2020

New 90-day low - CN¥27.93

New 90-day low - CN¥29.91

First half earnings released

Shandong Shanda Wit Science and Technology Co., Ltd. to Report First Half, 2020 Results on Aug 08, 2020

CEO

테뉴어

보상

이사회 구성원

평균 재임 기간

평균 연령